ZYUS Strengthens Expertise of Clinical Advisory Committee with the Appointment of Dr. Hance ClarkePosted by On

SASKATOON, Saskatchewan–(BUSINESS WIRE)– #HealthcareInnovations–ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company leading scientific research and global development of innovative cannabinoid-based pharmaceutical drug products, today announced the appointment of Hance Clarke, MD, PhD, FRCPC to ZYUS Life Sciences Inc.’s Clinical Advisory Committee. Dr. Clarke’s extensive background in healthcare and pain management aligns seamlessly with the committee’s mission to pro

Source link


Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.